Acalculous Cholecystitis


Epidemiology

Risk Factors

General Comments

  • Multiple Risk Factors are Present in Most Patients

Cardiovascular Disease

Critical Illness-Associated Disease

Gastrointestinal Disease

  • Ampullary Stenosis
  • Choledochal Cyst
  • Cystic Duct Obstruction by Bile Duct Percutaneous Transhepatic Catheter
  • Hemobilia (see Hemobilia, [[Hemobilia]])
  • Metastases to Porta Hepatis

Hematologic Disease

  • Acute Myeloid Leukemia (AML) (see Acute Myeloid Leukemia, [[Acute Myeloid Leukemia]])
  • Bone Marrow Transplant (BMT)/Stem Cell Transplant (SCT) (see Bone Marrow Transplant, [[Bone Marrow Transplant]])
    • Epidemiology: acalculous cholecystitis occurs in up to 4% of cases

Infectious Disease

Drugs

Other


Physiology

Secondary Infection with Organisms

  • General Comments: secondary infection with enteric pathogens occurs after acalculous cholecystitis is established
  • Bacteroides (see Bacteroides, [[Bacteroides]])
  • Escherichia Coli (see Escherichia Coli, [[Escherichia Coli]])
  • Enterococcus Faecalis (see Enterococcus Faecalis, [[Enterococcus Faecalis]])
  • Klebsiella (see Klebsiella, [[Klebsiella]])
  • Proteus (see Proteus, [[Proteus]])
  • Pseudomonas (see Pseudomonas, [[Pseudomonas]])

Diagnosis

Blood Culture (see Blood Culture, [[Blood Culture]])

Abdominal Ultrasound (see Abdominal-Pelvic Ultrasound, [[Abdominal-Pelvic Ultrasound]])

Cholescintigraphy (Nuclear Medicine Hepatobiliary Imaging) (see Cholescintigraphy, [[Cholescintigraphy]])


Clinical Manifestations

Gastrointestinal Manifestations

  • Gallbladder Perforation
    • Epidemiology: may occur in severe cases
  • RUQ Abdominal Pain (see Abdominal Pain, [[Abdominal Pain]])

Other Manifestations

  • Fever (see Fever, [[Fever]])

Treatment


Prognosis


References